Display options
Share it on

Psychiatry Investig. 2014 Apr;11(2):167-72. doi: 10.4306/pi.2014.11.2.167. Epub 2014 Apr 11.

Serum ghrelin and leptin levels in patients with depression and the effects of treatment.

Psychiatry investigation

Saliha Ozsoy, Aslı Besirli, Ummuhan Abdulrezzak, Mustafa Basturk

Affiliations

  1. Department of Psychiatry, Erciyes University School of Medicine, Kayseri, Turkey.
  2. Department of Psychiatry, Mus State Hospital, Mus, Turkey.
  3. Department of Nuclear Medicine, Erciyes University Medical School, Kayseri, Turkey.

PMID: 24843372 PMCID: PMC4023091 DOI: 10.4306/pi.2014.11.2.167

Abstract

OBJECTIVE: Ghrelin and leptin, appetite-regulating hormones, play a role in mood regulation. Current data about the relation between leptin/ghrelin and depression are still controversial. This study aimed to investigate serum leptin and ghrelin levels in patients with depression and the effects of treatment on these levels.

METHODS: Serum ghrelin and leptin levels were measured before and after treatment with antidepressant drugs and/or electroconvulsive therapy in 28 patients with depression and once in 21 healthy controls.

RESULTS: Serum ghrelin levels of the patients were high in the pre-treatment. After the treatment, ghrelin levels were not different from those of the controls. We found no difference in serum levels of leptin between the patients and controls and no change with treatment. body mass index of the patients increased after the treatment especially in the drug-treated group.

CONCLUSION: The present study found increased serum ghrelin levels in depressive patients and normalization with improving of depression but no alteration in leptin levels.

Keywords: Depression; Ghrelin; Leptin; Treatment

References

  1. Nat Neurosci. 2008 Jul;11(7):752-3 - PubMed
  2. J Psychiatr Res. 2011 Mar;45(3):421-6 - PubMed
  3. Clin Biochem. 2009 Jul;42(10-11):1076-81 - PubMed
  4. Neuropsychobiology. 2008;57(3):126-30 - PubMed
  5. Neuropsychopharmacology. 2005 Jun;30(6):1187-92 - PubMed
  6. J Clin Psychiatry. 2012 Sep;73(9):1205-11 - PubMed
  7. Neuropsychobiology. 2009;59(4):199-204 - PubMed
  8. Am J Clin Nutr. 2009 Mar;89(3):973S-979S - PubMed
  9. Endocrinology. 2011 Jul;152(7):2634-43 - PubMed
  10. Regul Pept. 2006 May 15;134(2-3):114-7 - PubMed
  11. Neuroendocrinology. 2001 Apr;73(4):243-7 - PubMed
  12. Brain Res. 2012 Sep 14;1473:185-92 - PubMed
  13. Regul Pept. 2012 Feb 10;174(1-3):12-7 - PubMed
  14. Neuroscience. 2011 Apr 28;180:201-11 - PubMed
  15. Diabetes. 2001 Apr;50(4):707-9 - PubMed
  16. Pharmacopsychiatry. 2002 Nov;35(6):220-5 - PubMed
  17. Curr Opin Pharmacol. 2007 Dec;7(6):648-52 - PubMed
  18. Endocrinology. 2003 Sep;144(9):3749-56 - PubMed
  19. Horm Metab Res. 1996 Dec;28(12):714-7 - PubMed
  20. Neuropsychopharmacology. 2000 Jul;23(1):13-9 - PubMed
  21. Prog Neuropsychopharmacol Biol Psychiatry. 2005 May;29(4):565-70 - PubMed
  22. J Clin Psychopharmacol. 2013 Feb;33(1):99-103 - PubMed
  23. J Clin Psychiatry. 2010 Aug;71(8):1079-87 - PubMed
  24. Mol Psychiatry. 2013 Jun;18(6):692-9 - PubMed
  25. Prog Neuropsychopharmacol Biol Psychiatry. 2008 Jan 1;32(1):135-9 - PubMed
  26. Proc Natl Acad Sci U S A. 2006 Jan 31;103(5):1593-8 - PubMed
  27. Neurosci Lett. 2007 Oct 9;426(1):49-53 - PubMed
  28. J Affect Disord. 2006 Jan;90(1):21-7 - PubMed
  29. J Clin Psychopharmacol. 2003 Dec;23(6):549-52 - PubMed
  30. Neuropsychopharmacology. 2006 Apr;31(4):832-44 - PubMed
  31. Stress. 2011 Sep;14(5):520-9 - PubMed

Publication Types